medigraphic.com
ISSN 2500-7106 (Electronic)
ISSN 0123-2576 (Print)
Medicina & Laboratorio

2013, Number 03-04

<< Back Next >>

Medicina & Laboratorio 2013; 19 (03-04)

Histopathological findings in cervical biopsies from patients with cytological diagnosis of atypical squamous cells of undetermined significance

Lozano BDM, Ruiz RJD, Pérez GMA, Escobar MFM, Gómez MIC, Arias RLF

Language: Spanish
References: 31
Page: 173-182
PDF size: 663.43 Kb.


ABSTRACT

Introduction: The term atypical squamous cells of undetermined significance refers to cytological changes suggestive of low-grade intraepithelial lesion that are insufficient for a definitive interpretation. In our region, there are no studies evaluating the frequency of dysplastic lesions in patients with atypical squamous cells of undetermined significance and there is no certainty about the most appropriate management. Aim: To describe the histopathological findings in biopsies or conizations performed after a diagnosis of atypical squamous cells of undetermined significance was made on cytology, and to de-termine the need for biopsy in these patients. Materials and Methods: We conducted a retrospective study of cases archived in the Department of Pathology for the year 2010. We included and reviewed all the cervical biopsies and conizations performed after a cytological diagnosis of atypical squamous cells of undetermined significance. For these cases, demographic data and histological findings were assessed. Results: During 2010, a total of 271 cervical histological studies were performed after a cytological diagnosis of atypical squamous cells of undetermined significance was given. In 25.1% of the patients the histological diagnosis was low-grade intraepithelial lesion; in 6.3% high-grade lesions were diagnosed, whereas in 68.6% of patients dysplasia was not found. Conclusions: Many patients with atypical squamous cells of undetermined significance have intraepithelial lesions and they should be studied with colposcopy or biopsy, or followed with periodic cytology. The proportion of patients with high-grade lesions was lower than the reported in other countries, which suggests the need to assess the quality of cervical cytology in our region.


REFERENCES

  1. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013; 132: 1133-1145.

  2. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88: 63-73.

  3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.

  4. Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D, Smith JS. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta- analysis. Am J Epidemiol 2008; 168: 123-137.

  5. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989; 261: 737-743.

  6. Gustafsson L, Ponten J, Zack M, Adami HO. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997; 8: 755-763.

  7. Solomon D, Nayar R, editors. The Bethesda system for reporting cervical cytology: definitions, criteria, and explanatory notes (ed 2). New York: Springer- Verlag; 2004.

  8. Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999; 91: 252-258.

  9. Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998; 92: 727-735.

  10. Safaeian M, Solomon D, Wacholder S, Schiffman M, Castle P. Risk of precancer and follow-up management strategies for women with human papillomavirus- negative atypical squamous cells of undetermined significance. Obstet Gynecol 2007; 109: 1325-1331.

  11. República de Colombia, Ministerio de Salud. Resolución 412 de 2000.

  12. República de Colombia, Ministerio de la Protección Social, Instituto Nacional de Cancerología . Recomendaciones para la tamización de neoplasias del cuello uterino en mujeres sin antecedentes de patología cervical (preinvasora o invasora) en Colombia. 2007. Disponible en http://www.cancer.gov.co/ documentos/RecomendacionesyGuias/GuiaN3.pdf Consultado en noviembre de 2012.

  13. Alanen KW, Elit LM, Molinaro PA, McLachlin CM. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. Cancer 1998; 84: 5-10.

  14. Bernard-Pearl L, Smith-McCune K. Controversies in the Management of ASCUS and AGCUS: Two very different beasts. Curr Probl Obstet Gynecol Fertil 2001; 24: 7-23.

  15. González-Mariño MA. Patología cervical y el reporte de ASCUS en la citología. Rev Colomb Obstet Ginecol 2003; 54: 193-198.

  16. Lachman MF, Cavallo-Calvanese C. Qualification of atypical squamous cells of undetermined significance in an independent laboratory: is it useful or significant? Am J Obstet Gynecol 1998; 179: 421-429.

  17. Piñeros M, Cendales R, Murillo R, Wiesner C, Tovar S. Cobertura de la citología de cuello uterino y factores relacionados en Colombia, 2005. Rev Salud Pública 2007; 9: 327-341.

  18. Murillo R, Almonte M, Pereira A, Ferrer E, Gamboa OA, Jeronimo J, et al. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine 2008; 26 Suppl 11: L37-48.

  19. Restrepo-Zea JH, Mejía-Mejía A, Valencia-Arredondo M, Tamayo-Acevedo LS, Salas-Zapata W. Accesibilidad a la citología cervical en Medellín, Colombia en 2006. Rev Esp Salud Pública 2007; 81: 657-666.

  20. Bravo M, Erazo JV, Álvarez AM, Casas MI, Ortiz de Collazos O, Álvarez-Soler J. Prevalencia de anormalidades en la citología cervical en tres grupos poblacionales de mujeres en Popayán, Colombia 2003-2005. Revista Colombiana de Obstetricia y Ginecología ; 59: 190-198. Rev Colomb Obstet Ginecol 2008; 59: 190- 198.

  21. González M, Murillo R, Osorio E, Gamboa O, Ardila J, Grupo de Investigación de Tamización en Cáncer de Cuello Uterino. Prevalencia de anormalidades citológicas e histológicas de cuello uterino en un grupo de mujeres en Bogotá, Colombia28. Rev Colomb Cancerol 2010; 14: 22-28.

  22. Grisales H, Vanegas AP, Gaviria AM, Castaño J, Mora MA, Borrero M, et al. Prevalencia de anormalidades de células epiteliales y factores asociados en mujeres de un municipio rural colombiano. Biomedica 2008; 28: 271-283.

  23. Tworek JA, Jones BA, Raab S, Clary KM, Walsh MK. The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions. Arch Pathol Lab Med 2007; 131: 1525- 1531.

  24. Sherman ME, Solomon D, Schiffman M. Qualification of ASCUS. A comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage Study. Am J Clin Pathol 2001; 116: 386-394.

  25. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003; 188: 1383-1392.

  26. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001; 93: 293-299.

  27. Herbst AL, Pickett KE, Follen M, Noller KL. The management of ASCUS cervical cytologic abnormalities and HPV testing: a cautionary note. Obstet Gynecol 2001; 98: 849-851.

  28. Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J. Virologic versus cytologic triage of women with equivocal Pap smears: a meta- analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004; 96: 280-293.

  29. Cox S. Guidelines for Papanicolaou test screening and follow-up. J Midwifery Womens Health 2012; 57: 86- 89.

  30. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012; 137: 516-542.

  31. Ostensson E, Froberg M, Hjerpe A, Zethraeus N, Andersson S. Economic analysis of human papillomavirus triage, repeat cytology, and immediate colposcopy in management of women with minor cytological abnormalities in Sweden. Acta Obstet Gynecol Scand 2010; 89: 1316-1325.




2020     |     www.medigraphic.com